Hormonal contraception use may raise odds of starting semaglutide
Healio reports on a Danish nested case-control study, presented at the European Association for the Study of Diabetes meeting, linking hormonal contraception use with higher odds of starting semaglutide. Researchers compared 22,694 girls and women aged 12 to 49 years who first used semaglutide with 229,640 controls. The association is observational, and the lead author cautioned against drawing a direct arrow between the two.
Why it matters: Relevant to clinicians who prescribe contraception or semaglutide, and to women considering medical weight loss who follow registry research on these medications.
A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to healio.com. October 12, 2026.
